Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA; ALTITUDE Investigators.

N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3.

2.

Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.

Köster R, Kaehler J, Meinertz T; REDUCTION Study Group.

Am Heart J. 2009 Oct;158(4):e51-7. doi: 10.1016/j.ahj.2009.06.008.

PMID:
19781403
3.

Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.

Faergeman O, Hill L, Windler E, Wiklund O, Asmar R, Duffield E, Sosef F; ECLIPSE Study Investigators.

Cardiology. 2008;111(4):219-28. doi: 10.1159/000127442. Epub 2008 Apr 23.

PMID:
18434729
4.

[Acupuncture covered by national health insurance?].

Suchant G, Hohenstatt T.

MMW Fortschr Med. 2000 Nov 23;142(47):14. German. No abstract available.

PMID:
11143774

Supplemental Content

Loading ...
Support Center